Episode #11 - Human Sexuality Discussion on the Major Trends in Human Sexual Behavior, Sexual Desire,
Satisfaction and Sexual Dysfunction Issues
NEW YORK, Nov. 16 /PRNewswire/ --
WHAT: Are medicine and technology changing human sexuality? Does gender
equality lead to better sex lives? What role does sex play in the
quality of life of people in their post-reproductive periods? These
and other compelling issues on human sexuality will be the focus of
the upcoming episode of the Charlie Rose Science Series. A
distinguished group will also explore the physiological
and psychological aspects of human sexuality -- including causes of
sexual dysfunction, differences between men and women when it comes
to sex, fertility, the relationship between sexual performance and
WHO: Guests will include:
-- Ridwan Shabsigh, MD, Associate Professor of Urology at the
College of Physicians and Surgeons, Columbia University
-- Julia Heiman, PhD, Psychologist and Director, Kinsey Institute
for Research in Sex, Gender, and Reproduction
-- Anita H. Clayton, MD, David C. Wilson Professor of Psychiatry,
University of Virginia Health System
-- Edward O. Laumann, PhD, Director, Ogburn Stouffer Center for
Population and Social Organization, University of Chicago
WHEN: Begins Airing on November 20, 2007 on PBS stations. Check your
local PBS listings for show times.
The Charlie Rose Science Series sponsored by Pfizer Inc. is an exploration of modern advances in scientific research, their contribution to our understanding of the world around us, and how science breakthroughs can be applied to improving human health.
Charlie Rose is joined in this effort by his co-host, Sir Paul Nurse, PhD, Nobel Laureate and President of Rockefeller University.
As a world leader in research and development, Pfizer is committed to increasing public understanding of science and science education. For more information about The Charlie Rose Science Series or to watch clips from past episodes, please visit http://www.charlierose.com.
|SOURCE Charlie Rose|
Copyright©2007 PR Newswire.
All rights reserved